Validation of Czech versions of questionnaires assessing female sexual function and pelvic floor function

Czech version

Authors: B. Heřmánková ¹; H. Šmucrová ²; M. Mikulášová ²; S. Oreská ^2,3; M. Špiritović ^1,2; H. Štorkánová ^2,3; M. Tomčík ^2,3
Authors‘ workplace: Fakulta tělesné výchovy a sportu, Katedra fyzioterapie, Univerzita Karlova, Praha ¹; Revmatologický ústav Praha ²; Revmatologická klinika 1. lékařské fakulty, Univerzita Karlova, Praha ³
Published in: Čes. Revmatol., 29, 2021, No. 1, p. 30-40.
Category:

Overview

Rheumatic diseases can affect all aspects of life, including sexual function. The etiologies of sexual dysfunctions in rheumatic diseases are often multifactorial and include factors associated with both disease and therapy. Sexual dysfunction may also be related to pelvic floor dysfunction. Recent studies suggested a high prevalence of sexual dysfunction among patients with rheumatic diseases. This work aimed to perform the Czech translation and linguistic validation of questionnaires evaluating the female sexual function and pelvic floor function: Female Sexual Function Index (FSFI), Brief Index of Sexual Functioning for Women (BISF-W), Sexual Function Questionnaire – 28 items (SFQ28), Sexual Quality of Life Questionnaire – Female (SQoL-F), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire – short form (PISQ-12) and Pelvic Floor Impact Questionnaire – short form 7 (PFlQ-7). The original versions of the questionnaires were translated by two independent bilingual health professionals and consensually discussed and synthesized by the authors of this paper. In the next step, six bilingual non-physicians commented on the linguistic and content aspects of the questionnaires, and their comments were taken into account by an expert panel. Subsequently, two independent blinded translators carried out a back-translation. Consensually, pre-final Czech versions of the questionnaires were created, which were afterward completed by 41 female patients with rheumatoid arthritis (RA), 30 female patients with systemic lupus erythematosus (SLE), 50 female patients with idiopathic inflammatory myopathies (IIM), 70 female patients with systemic sclerosis (SSc) and 191 healthy women matched for age. A feedback questionnaire was used to assess the comprehensibility and conciseness of each question. The expert panel considered the patients’ comments when creating the definitive Czech versions of the questionnaires. This work has resulted in the creation of Czech versions of the FSFI, BISF-W, SFQ28, SQoL-F, PISQ-12, and PFIQ-7 questionnaires. All questionnaires proved to be understandable. Patients with RA, SLE, IIM, and SSc achieved scores that were numerically similar to the results of previously published studies. These questionnaires may be appropriate tools to be used in clinical research and routine clinical practice.

Keywords:

Patient-Reported Outcomes – sexual function – pelvic floor function – linguistic validation

Sources

1. World Health Organization. Defining sexual health: report of a technical consultation on sexual health, 28–31 January 2002, Geneva: World Health Organization; 2006.

2. Orzúa-de la Fuente WM, Salazar-Hernández GJ, Vega-Morales D, Garza-Alpírez A, Esquivel-Valerio JA. High Prevalence of Sexual Dysfunction in Women with Rheumatic Diseases: A not Recognized Health Domain. Sexuality and Disability 2018; 36(4): 407–416.

3. World Health Organization. ICD–11 for Mortality and Morbidity Statistics: Sexual dysfunctions. [online] ©2018; Version: 09/2020: Available from: https://icd.who.int/browse11/l–m/en#/http://id.who.int/icd/entity/160690465.

4. McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016; 13(2): 153–167.

5. Akkurt HE, Yilmaz H, Yilmaz S, Parlak L, Ordahan B, Salli A. Evaluation of sexual dysfunction in females with ankylosing spondylitis. ArchRheumatol 2016; 31(1): 41.

6. Moghadam ZB, Rezaei E, Faezi ST, Zareian A, Ibrahim FM, Ibrahim MM. Prevalence of sexual dysfunction in women with systemic lupus erythematosus and its related factors. Reumatologia 2019; 57(1): 19.

7. Østensen M. Sexual and reproductive health in rheumatic disease. Nat Rev Rheumatol 2017; 13(8): 485–493.

8. Zhao S, Li E, Wang J, Luo L, Luo J, Zhao Z. Rheumatoid arthritis and risk of sexual dysfunction: a systematic review and metaanalysis. J Rheumatol 2018; 45(10): 1375–1382.

9. Tristano AG. The impact of rheumatic diseases on sexual function. Rheumatol Int 2009; 29(8): 853–860.

10. Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril 2013; 100(4): 898–904.

11. Giraldi A, Rellini A, Pfaus JG, Bitzer J, Laan E, Jannini EA, et al. Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. J Sex Med 2011; 8(10): 2681–2706.

12. Rosen CB, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D’Agostino R. The Female Sexual Function Index (FSFI): a multidimensional self–report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26(2): 191–208.

13. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31(1): 1–20.

14. Neijenhuijs KI, Hooghiemstra N, Holtmaat K, Aaronson NK, Groenvold M, Holzner B, et al. The Female Sexual Function Index (FSFI) – a systematic review of measurement properties. J Sex Med 2019; 16(5): 640–660.

15. Nowosielski K, Wróbel B, Sioma-Markowska U, Poręba R. Development and validation of the Polish version of the Female Sexual Function Index in the Polish population of females. J Sex Med 2013; 10(2): 386–395.

16. Bongi SM, del Rosso A, Mikhaylova S, Baccini M, Cerinic MM. Sexual function in Italian women with systemic sclerosis is affected by disease–related and psychological concerns. J Rheumatol 2013; 40(10): 1697–1705.

17. Zhang Q, Zhou C, Chen H, Zhao Q, Li L, Cui Y, et al. Rheumatoid arthritis is associated with negatively variable impacts on domains of female sexual function: evidence from a systematic review and meta-analysis. Psychol Health Med 2018; 23(1): 114–125.

18. Reynolds III CF, Frank E, Thase ME, Houck PR, Jennings JR, Howell JR, et al. Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men. Psychiatry Res 1988; 24(3): 231–250.

19. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: psychometric evaluation of the Brief Index of Sexual Functioning for Women. Arch Sex Behav 1994; 23(6): 627–643.

20. Mazer NA, Leiblum SR, Rosen RC. The brief index of sexual functioning for women (BISF–W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 2000; 7(5): 350–363.

21. Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001; 27(5): 411–420.

22. Lobo RA, Rosen RC, Yang H-M, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003; 79(6): 1341–1352.

23. Ferrucci R, Panzeri M, Ronconi L, Ardolino G, Cogiamanian F, Barbieri S, et al. Abnormal sexuality in Parkinson’s disease: fact or fancy? J Neurol Sci 2016; 369: 5–10.

24. Timmer A, Bauer A, Dignass A, Rogler G. Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 2007; 5(1): 87–94.

25. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2002; 11(3): 277–289.

26. Quirk F, Haughie S, Symonds T. The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction. J Sex Med 2005; 2(4): 469–477.

27. Symonds T, Abraham L, Bushmakin AG, Williams K, Martin M, Cappelleri JC. Sexual function questionnaire: further refinement and validation. J Sex Med 2012; 9(10): 2609–2616.

28. Malik S, Fenton B. The effect of lifelong dysmenorrhea on sexual function in women with chronic pelvic pain. Fertil Steril 2010; 94(4): S59.

29. Song M, Ishii H, Toda M, Tomimatsu T, Katsuyama H, Nakamura T, et al. Association between sexual health and delivery mode. Sex Med 2014; 2(4): 153–158.

30. Stadnicka G, Łepecka-Klusek C, Kulesza-Brończyk B, Pilewska--Kozak A. The quality of life of women suffering from polycystic ovary syndrome. Progress in Health Sciences 2015; 5(2): 61–68.

31. Turini T, Weck Roxo AC, Serra-Guimarães F, Abreu ML, de Castro CC, Aboudib JH, et al. The impact of labiaplasty on sexuality. Plast Reconstr Surg 2018; 141(1): 87–92.

32. Symonds T, Boolell M, Quirk F. Development of a questionnaire on sexual quality of life in women. J Sex Marital Ther 2005; 31(5): 385–397.

33. Li SJ, Huang KP, Joyce C, Mostaghimi A. The impact of alopecia areata on sexual quality of life. International Journal of Trichology 2018; 10(6): 271.

34. Lew-Starowicz M, Rola R. Sexual quality of life in women with multiple sclerosis. Przeglad Menopauzalny 2012; 16(5): 381.

35. Ekemen A, Beydağ KD. Quality of sexual life and factors affecting it in married women undergoing depression treatment. Perspect Psychiatr Care 2020.

36. Almont T, Delannes M, Ducassou A, Corman A, Bondil P, Moyal E, et al. Sexual quality of life and needs for sexology care of cancer patients admitted for radiotherapy: A 3-month cross-sectional study in a regional comprehensive reference cancer center. J Sex Med 2017; 14(4): 566–576.

37. Owiredu W, Alidu H, Amidu N, Obirikorang C, Gyasi-Sarpong C, Bawah A, et al. Sexual dysfunction among diabetics and its impact on the SQoL of their partners. Int J Impot Res 2017; 29(6): 250–257.

38. Berg KH, Rohde GE, Prøven A, Benestad EEP, Østensen M, Haugeberg G. Sexual quality of life in patients with axial spondyloarthritis in the biologic treatment era. J Rheumatol 2019; 46(9): 1075–1083.

39. Aschkenazi SO, Goldberg RP. Female sexual function and the pelvic floor. Expert Review of Obstetrics & Gynecology 2009; 4(2): 165–178.

40. Rosenbaum TY. REVIEWS: Pelvic floor involvement in male and female sexual dysfunction and the role of pelvic floor rehabilitation in treatment: a literature review. J Sex Med 2007; 4(1): 4–13.

41. Grigoriadis T, Athanasiou S, Rizk D. Female pelvic floor dysfunction questionnaires: the modern Tower of Babel? Int Urogynecol J 2020; 31(6): 1059–1061.

42. Abrams P, Andersson K-E, Apostolidis A, Birder L, Bliss D, Brubaker L, et al. 6^th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn 2018; 37(7): 2271–2272.

43. la Rosa VL, Ciebiera M, Lin L-T, Sleiman Z, Cerentini TM, Lordelo P, et al. Multidisciplinary management of women with pelvic organ prolapse, urinary incontinence and lower urinary tract symptoms. A clinical and psychological overview. Prz Menopauzalny 2019; 18(3): 184.

44. Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C. A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 2001; 184(4): 552–558.

45. Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J 2003; 14(3): 164–168.

46. A‘t Hoen L, Utomo E, Steensma AB, Blok BF, Korfage IJ. The pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12): validation of the Dutch version. A short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J 2015; 26(9): 1293–1303.

47. Fatton B, Letouzey V, Lagrange E, Mares P, Jacquetin B, de Tayrac R. Validation of a French version of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ–12). J Gynecol Obstet Biol Reprod (Paris) 2009; 38(8): 662–667.

48. Santana GWRM, Aoki T, Auge APF. The Portuguese validation of the short form of the pelvic organ prolapse/urinary incontinence sexual questionnaire (PISQ-12). Int Urogynecol J 2012; 23(1): 117–121.

49. Glavind K, Larsen T, Lindquist ASI. Sexual function in women before and after surgery for pelvic organ prolapse. Acta Obstet Gynecol Scand 2015; 94(1): 80–85.

50. Urwitz-Lane R, Özel B. Sexual function in women with urodynamic stress incontinence, detrusor overactivity, and mixed urinary incontinence. Am J Obstet Gynecol 2006; 195(6): 1758–1761.

51. Adams K, Osmundsen B, Gregory WT. Does fibromyalgia influence symptom bother from pelvic organ prolapse? Int Urogynecol J 2014; 25(5): 677–682.

52. Rušavý Z, Nečesalová P, Rinnová E, Smažinka M, Havíř M, Kališ V. Český překlad a validace dotazníku kvality pohlavního života u žen s prolapsem pánevních orgánů či inkontinencí moči nebo stolice – PISQ-IR. Ces Gynekol 2017; 82(2): 129–138.

53. Barber M, Walters M, Bump R. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005; 193(1): 103–113.

54. Buss ML, Clinton SC. Pelvic Floor Functional and Impairment Limitations in a Female With Hip Osteoarthritis. Topics in Geriatric Rehabilitation 2013; 29(4): 239–245.

55. Cetin SY, Buyuk A, Ayan A. Investigation of the relationship between the pelvic floor and sexual dysfunction in women with Sjögren’s syndrome. Int J Rheum Dis 2020; 00: 1–6.

56. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000; 25(24): 3186–3191.

57. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham III CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569–2581.

58. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64(8): 2677–2686.

59. van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65(11): 2737–2747.

60. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292(7): 344–347.

61. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292(8): 403–407.

62. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119^th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14(5): 337–345.

63. Aras H, Aras B, Icagasioglu A, Yumusakhuylu Y, Kemahli E, Haliloglu S, et al. Sexual dysfunction in women with rheumatoid arthritis. Med Glas (Zenica) 2013; 10(2).

64. Coskun B, Coskun BN, Atis G, Ergenekon E, Dilek K. Evaluation of sexual function in women with rheumatoid arthritis. Urol J 2014; 10(4): 1081–1087.

65. Hari A, Rostom S, Lahlou R, Bahiri R, Hajjaj-Hassouni N. Sexual function in Moroccan women with rheumatoid arthritis and its relationship with disease activity. Clin Rheumatol 2015; 34(6): 1047–1051.

66. Maasoumi R, Moridi M, Farhadi F, Moshfeghi Z. Sexual function in women with rheumatoid arthritis. Women’s Health Bulletin 2014; 1(2).

67. Souza FHCd, Araújo DBd, Silva CA, Miossi R, Abdo CHN, Bonfá E, et al. Analysis of sexual function of patients with dermatomyositis and polymyositis through self-administered questionnaires: a cross-sectional study. Rev Bras Reumatol Engl Ed 2017; 57(2): 134–140.

68. Schouffoer A, van der Marel J, Ter Kuile M, Weijenborg P, Voskuyl A, Vliet Vlieland C, et al. Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum 2009; 61(11): 1601–1608.

Labels

Dermatology & STDs Paediatric rheumatology Rheumatology

ÚVODNÍK

Pavelka K. and the Committee of the Czech Society for Rheumatology. Recommendations of the Czech Society for Rheumatology the Pharmacological Treatment of Axial Spondyloarthritis Part I. Treatment and pharmacotherapy strategies

The fate of a knee after partial meniscectomy: a review of radiological and clinical outcomes with at least 5-year follow-up

Ukazatele aktivity a funkčního postižení u revmatoidní artritidy

Risks of long-term bisphosphonate treatment

Article was published in

Czech Rheumatology

2021 Issue 1